Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms
Yu Mi Wi(Mayo Clinic), Robin Patel(Mayo Clinic in Arizona), Kerryl E. Greenwood‐Quaintance(Mayo Clinic), Kyong Ran Peck(Samsung Medical Center), Kwan Soo Ko(Sungkyunkwan University), Audrey N. Schuetz(Mayo Clinic), Jae‐Hoon Song(Sungkyunkwan University)
Cited by 66
Related Papers
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|3k
Rapid Pneumococcal Evolution in Response to Clinical Interventions
|Science|2011|912
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
|Clinical Infectious Diseases|2018|618